DANIEL MUSHER to Bacterial Vaccines
This is a "connection" page, showing publications DANIEL MUSHER has written about Bacterial Vaccines.
Connection Strength
1.450
-
IgG responses to protein-conjugated pneumococcal capsular polysaccharides in persons who are genetically incapable of responding to unconjugated polysaccharides. Clin Infect Dis. 1998 Dec; 27(6):1487-90.
Score: 0.154
-
Pneumococcal outbreaks in nursing homes. N Engl J Med. 1998 Jun 25; 338(26):1915-6.
Score: 0.150
-
Polysaccharide vaccines: determinants of clinical efficacy. Hosp Pract (1995). 1997 Sep 15; 32(9):37-8, 41-4, 52-3 passim.
Score: 0.142
-
Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J Investig Med. 1997 Feb; 45(2):57-68.
Score: 0.136
-
IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis. 1996 Jun; 173(6):1347-53.
Score: 0.130
-
The lack of association between aging and postvaccination levels of IgG antibody to capsular polysaccharides of Streptococcus pneumoniae. Clin Infect Dis. 1996 Jan; 22(1):165-7.
Score: 0.126
-
Pneumococcal vaccination for patients with spinal cord injury. Arch Phys Med Rehabil. 1993 Dec; 74(12):1354-7.
Score: 0.109
-
Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis. 1990 Apr; 161(4):728-35.
Score: 0.085
-
Vaccination of 18-month-old children with conjugated polyribosyl ribitol phosphate stimulates production of functional antibody to Haemophilus influenzae type b. Pediatr Infect Dis J. 1988 Mar; 7(3):156-9.
Score: 0.073
-
Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis. 1986 Aug; 154(2):245-56.
Score: 0.066
-
Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis. 1999 Aug; 29(2):281-8.
Score: 0.040
-
The role of a vaccine for syphilis. Sex Transm Dis. 1977 Oct-Dec; 4(4):163-6.
Score: 0.036
-
Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis. 1996 Jan; 173(1):83-90.
Score: 0.032
-
Pneumococcal virulence factors and host immune responses to them. Eur J Clin Microbiol Infect Dis. 1995 Jun; 14(6):479-90.
Score: 0.030
-
Pneumococcal vaccine after 15 years of use. Another view. Arch Intern Med. 1994 Nov 28; 154(22):2531-5.
Score: 0.029
-
Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin Infect Dis. 1993 Jul; 17(1):66-73.
Score: 0.027
-
Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis. 1992 Mar; 165(3):553-6.
Score: 0.024
-
Pneumococcal pneumonia including diagnosis and therapy of infection caused by penicillin-resistant strains. Infect Dis Clin North Am. 1991 Sep; 5(3):509-21.
Score: 0.023
-
Pneumococcal vaccination: work to date and future prospects. Am J Med Sci. 1990 Jul; 300(1):45-52.
Score: 0.022
-
Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination. J Infect Dis. 1986 Dec; 154(6):935-43.
Score: 0.017